Aequus Pharmaceuticals Stock Price Prediction

Intrinsic Valuation Low Real High 0.00 0.01 6.93 Details

Naive Forecast Low Next High 0.0002 0.01 6.93 Details

Bollinger Band Projection (param) Lower Middle Band Upper 0.01 0.01 0.01 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aequus Pharmaceuticals. Your research has to be compared to or analyzed against Aequus Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Aequus Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Aequus Pharmaceuticals.

Aequus Pharmaceuticals After-Hype Price Prediction Density Analysis

Aequus Pharmaceuticals Estimiated After-Hype Price Volatility

Aequus Pharmaceuticals OTC Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.94	6.92	0.00	0.02	0 Events / Month	5 Events / Month	In 5 to 10 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
0.01	0.01	23.64	0.00   Notes

Aequus Pharmaceuticals Hype Timeline

Aequus Pharmaceuticals is presently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Aequus is forecasted to increase in value after the next headline, with the price projected to jump to 0.008161 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is projected to be 23.64%, whereas the daily expected return is presently at -0.94%. The volatility of related hype on Aequus Pharmaceuticals is about 29136.84%, with the expected price after the next announcement by competition of 0.03. Aequus Pharmaceuticals has accumulated 26.09 K in total debt with debt to equity ratio (D/E) of 1.39, which is about average as compared to similar companies. Aequus Pharmaceuticals has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Aequus Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Aequus Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aequus Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aequus to invest in growth at high rates of return. When we think about Aequus Pharmaceuticals' use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next forecasted press release will be in 5 to 10 days. Check out Aequus Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Aequus Pharmaceuticals Related Hype Analysis

Aequus Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Aequus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aequus using various technical indicators. When you analyze Aequus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Aequus Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aequus Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aequus Pharmaceuticals based on analysis of Aequus Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Aequus Pharmaceuticals depends on current market conditions and Aequus Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aequus Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aequus Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Aequus Pharmaceuticals' future price predictability will typically decrease when Aequus Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aequus Pharmaceuticals often depends not only on the future outlook of the potential Aequus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aequus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.

When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.